Press Release – New York, NY – August 3, 2026 – Sichenzia Ross Ference Carmel LLP announced that it represented 60 Degrees Pharmaceuticals, Inc. (Nasdaq: SXTP, SXTPW), a pharmaceutical company that develops and commercializes new medicines for vector-borne disease, in its recently priced $1 million private placement.
The SRFC team was led by partner Ross Carmel, with associates Jesse Blue and Leanne Li.